Bridgewater Advisors Inc. Dexcom Inc Transaction History
Bridgewater Advisors Inc.
- $1.15 Billion
- Q1 2025
A detailed history of Bridgewater Advisors Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Bridgewater Advisors Inc. holds 12,636 shares of DXCM stock, worth $1.13 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,636
Previous 13,017
2.93%
Holding current value
$1.13 Million
Previous $1.01 Million
14.82%
% of portfolio
0.07%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding DXCM
# of Institutions
1,091Shares Held
363MCall Options Held
5.74MPut Options Held
4.65M-
Vanguard Group Inc Valley Forge, PA47.5MShares$4.23 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.07 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.49 Billion0.05% of portfolio
-
Baillie Gifford & CO14.2MShares$1.26 Billion0.87% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$1.07 Billion0.19% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...